Current Securities Fraud Investigations

Stock Losses Under Review | Serving PA, NJ, NY, MD & DC

Short answer. This page lists the public companies the Siddons Law Firm is currently investigating for investors. Each one had a sharp fall in its stock price after bad news about the company came out. If you lost $100,000 or more in one of these stocks, or you are a current or former employee of one of these companies, email msiddons@siddonslaw.com.

Last updated October 25, 2026.

Which Companies Is the Firm Investigating?

Company What happened Stock drop Purchases under review
Duolingo (NASDAQ: DUOL) Third-quarter 2025 results showed user growth slowing and the company eased off its monetization push (November 5, 2025); the chief financial officer resigned (January 12, 2026); 2026 user guidance came in weak (February 26, 2026). A class action is on file in the Western District of Pennsylvania; the deadline to ask to lead it is December 7, 2026. 25 percent, 8.5 percent and 14 percent May 2, 2025 through February 26, 2026
Chemours (NYSE: CC) Second-quarter 2026 results showed falling aftermarket sales of Opteon refrigerants and the company cut its full-year earnings guidance (August 4, 2026). A class action is on file in the District of Delaware; the deadline to ask to lead it is December 7, 2026. 18.6 percent February 20, 2026 through August 4, 2026
Fluence Energy (NASDAQ: FLNC) Guidance cut three times in 2026, the last a mid-quarter cut of about $600 million in full-year revenue (September 16, 2026). A class action is on file in the Southern District of New York; the deadline to ask to lead it is November 27, 2026. 15.4 percent November 24, 2025 through September 16, 2026
AppLovin (NASDAQ: APP) An analyst reported slowing e-commerce advertising growth (July 13, 2026); quarterly revenue missed and the company blamed delays in its AI video advertising tool (August 5, 2026). A class action is on file in the Northern District of California; the deadline to ask to lead it is November 16, 2026. 12.6 percent and 19.6 percent February 12, 2026 through August 5, 2026
AST SpaceMobile (NASDAQ: ASTS) Analyst downgrades over competition, slow adoption and launch delays, then a $1 billion convertible note offering (July 15, 2026). A class action is on file in the Western District of Texas; the deadline to ask to lead it is November 13, 2026. 17 percent March 4, 2025 through July 15, 2026
D-Wave Quantum (NYSE: QBTS) Second-quarter revenue of $3.08 million against expectations of about $4 million (August 6, 2026); the chief financial officer resigned (August 25, 2026). No class action filed yet. More than 9 percent, twice 2026 through August 25, 2026
AEVEX (NYSE: AVEX) A news report on October 20, 2026 said the U.S. Navy had stopped new orders of GARC unmanned boats made by BlackSea Technologies, which AEVEX bought in September 2026. AEVEX said no orders were halted but that no additional GARC vessels were planned for procurement. An earlier case on the April 2026 IPO does not cover this news. 32.5 percent (October 21, 2026) August 12, 2026 through October 20, 2026
Fervo Energy (NASDAQ: FRVO) Short seller report published October 6, 2026 questioning the performance of the company’s geothermal wells, after a May 12, 2026 IPO at $27.00. No case has been filed as of October 20, 2026. 16.6 percent (August 12, 2026); down 66 percent from the IPO price May 12, 2026 (IPO) through October 6, 2026
Compass (NYSE: COMP) Reports, confirmed by the New York Attorney General’s office, of an antitrust investigation into Compass’s market share after its merger with Anywhere Real Estate (June 3, 2026). A class action is on file; the deadline to ask to lead it is December 8, 2026. 11.8 percent January 9, 2026 through June 3, 2026
Webull (NASDAQ: BULL) A committee of the U.S. House of Representatives released a report on Webull’s links to China (October 7, 2026). A class action is on file; the deadline to ask to lead it is December 7, 2026. 19.1 percent April 26, 2025 through October 6, 2026
Medline (NASDAQ: MDLN) An FDA warning letter about its Waukegan, Illinois drug plant became public (June 2, 2026). The company cut its 2026 profit outlook (August 5, 2026). 7.2 percent and 12.8 percent December 17, 2025 through August 4, 2026

An investigation is not a finding. No court has found that any company on this list or its officers did anything wrong.

Who Should Contact the Firm?

  • Investors who lost $100,000 or more in one of the stocks listed above.
  • Trusts, estates, retirement plans, partnerships and businesses that held one of these stocks.
  • Current and former employees of a listed company who know firsthand what the company knew.

See Securities Fraud Cases We Take for the full description of the clients and cases we are looking for.

My Stock Is Not on This List. Can I Still Email?

Yes. Email msiddons@siddonslaw.com with the name of the company, the dates you bought and sold, the number of shares and your approximate loss. We review stock drops every business day and add companies as they qualify.

Frequently Asked Questions

What does it mean that the firm is investigating a company?

It means we are reviewing the company’s public statements and filings to decide whether investors have a claim under the federal securities laws. It does not mean a lawsuit has been filed, and it does not mean the company did anything wrong.

How does a company get on this list?

The company is listed on the New York Stock Exchange or NASDAQ, its stock fell sharply after a disclosure, and its earlier statements to investors appear to conflict with what it later disclosed.

What does it cost to have my loss reviewed?

The first conversation is free. If we take your matter, the fee terms are put in writing before any work begins.